2023 Abstracts

All participants are highly encouraged to submit an abstract. Online abstract submissions will be accepted starting March 2023 and run through June 16th; with a late breaking abstract period in August. You must register for the meeting prior to submitting an abstract. Abstracts submitted by June 16th will be considered for oral, poster, and/or poster flash talk presentations* and are also eligible for award and grant consideration. Late breaking abstracts will be considered for poster presentations only. To submit an abstract, register for the meeting and then follow the links provided. Conference abstracts will be available to all participants as a PDF on the website and on the meeting app. Abstract submission is free for members.

Submissions will be accepted in the following categories through June 16th:

  • Immune Responses to Emerging Viral Pathogens
  • Innovations in Autoimmunity
  • New Frontiers in Cancer Immunotherapy
  • Unexpected Advances in Leukocyte Biology
  • Adaptive Immunity in Cancer
  • Dysregulation of Adaptive Immunity
  • Dysregulation of Innate Immunity
  • Immunity to Microbial Pathogens
  • Innate Immunity in Cancer
  • Novel Concepts in Immunology
  • Surprising Big Data Insights in Immunity
  • Technological Innovations in Immunology

* Abstracts will be consider for oral OR poster presentation.  If an abstract is selected to present orally in a concurrent session, no poster display will be provided. If an abstract is selected as a poster flash talk, these submissions will have both a flash talk and a poster display.


Special Opportunity with JLB

Be a part of a Special JLB Dedicated SLB 2023 Meeting Issue.

The Journal of Leukocyte Biology will publish a Special Focus issues with articles related to the SLB 2023 meeting, both review papers ("overviews") and original investigations. Submissions will be welcomed from all meeting participants, and all will be peer-reviewed according to the high standards of the JLB. Look for the schedule for submission onsite at the meeting.